JIN Ye, ZHONG Yu. Tuoli Xiaodu Powder combined with Qianjin Weijing Decoction in treatment of peritonitis and peritoneal dialysis catheter-related infection: case analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 61-63. DOI: 10.7619/jcmp.20232889
Citation: JIN Ye, ZHONG Yu. Tuoli Xiaodu Powder combined with Qianjin Weijing Decoction in treatment of peritonitis and peritoneal dialysis catheter-related infection: case analysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(8): 61-63. DOI: 10.7619/jcmp.20232889

Tuoli Xiaodu Powder combined with Qianjin Weijing Decoction in treatment of peritonitis and peritoneal dialysis catheter-related infection: case analysis

More Information
  • Received Date: September 11, 2023
  • Revised Date: November 20, 2023
  • Available Online: May 05, 2024
  • Patients are prone to present peritonitis and catheter-related infections during peritoneal dialysis treatment, and the combined treatment of vancomycin and cefoperazone sulbactam fails to achieve the satisfactory anti-infective effect, but the combined treatment of Tuoli Xiaodu Powder and Qianjin Weijing Decoction can effectively control the infection. The patient's illness was protracted, with insufficient vital energy and the invasion of pathogenic factors, so the treatment was focused on invigorating qi and enriching blood, clearing heat and detoxifying, and removing abscesses. Tuoli Xiaodu Powder combined with Qianjin Weijing Decoction with modifications can timely control the patient's infection and provide a new option for clinical treatment of peritonitis and catheter-related infections.

  • [1]
    DAVIES S J, OGG C S, CAMERON J S, et al. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD)[J]. Perit Dial Int, 1989, 9(1): 61-64. doi: 10.1177/089686088900900112
    [2]
    LI P K T, SZETO C C, PIRAINO B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment[J]. Perit Dial Int, 2016, 36(5): 481-508. doi: 10.3747/pdi.2016.00078
    [3]
    VAN DIEPEN A T, TOMLINSON G A, JASSAL S V. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients[J]. Clin J Am Soc Nephrol, 2012, 7(8): 1266-1271. doi: 10.2215/CJN.00980112
    [4]
    NATAATMADJA M, CHO Y, PASCOE E M, et al. Association between peritoneal glucose exposure and peritonitis in peritoneal dialysis patients: the balANZ trial[J]. Perit Dial Int, 2017, 37(4): 407-413. doi: 10.3747/pdi.2016.00263
    [5]
    盛维忠. 薛立斋医学全书[M]. 2版. 北京: 中国中医药出版社, 2015: 1-20.
    [6]
    王东生. 托里消毒散结合负压引流治疗正虚邪滞型小腿骨折术后感染[D]. 福州: 福建中医药大学, 2012.
    [7]
    赵玉洁. 中西医结合治疗肺脓肿疗效分析[J]. 贵阳中医学院学报, 1997, 19(2): 13-14. https://www.cnki.com.cn/Article/CJFDTOTAL-GYZX199702007.htm
    [8]
    杨泽兵, 高卫星, 李声. 脓肿引流配合千金苇茎汤治疗肺脓肿36例[J]. 中国中西医结合急救杂志, 2005, 12(3): 152. doi: 10.3321/j.issn:1008-9691.2005.03.025
    [9]
    黄万贯, 万娟. 麻杏石甘汤合千金苇茎汤治疗老年慢阻肺疗效研究[J]. 内蒙古中医药, 2019, 38(12): 14-15. https://www.cnki.com.cn/Article/CJFDTOTAL-NZYY201912009.htm
    [10]
    杨栓柱, 王文, 李猛, 等. 千金苇茎汤合瓜蒌薤白杏仁汤治疗慢性阻塞性肺疾病急性加重期临床研究[J]. 陕西中医, 2019, 40(5): 600-603. doi: 10.3969/j.issn.1000-7369.2019.05.016
    [11]
    王东生. 托里消毒散结合负压引流治疗正虚邪滞型小腿骨折术后感染[D]. 福州: 福建中医药大学, 2012.
    [12]
    蔡汝超, 盛梅笑. 中药黄芪应用于腹膜透析治疗中的研究概况[J]. 中国中西医结合肾病杂志, 2010, 11(2): 181-183. doi: 10.3969/j.issn.1009-587X.2010.02.039
    [13]
    黄一新, 易苗英, 傅娟芳, 等. 高糖与炎症因子及黄芪对人腹膜间皮细胞毒性的影响[J]. 中国中西医结合肾病杂志, 2003, 4(5): 262-264. doi: 10.3969/j.issn.1009-587X.2003.05.005
    [14]
    范红英, 郑智华. 黄芪注射液对大鼠腹膜细胞凋亡与增殖平衡的作用[J]. 中国中西医结合急救杂志, 2004, 11(3): 154-155. doi: 10.3321/j.issn:1008-9691.2004.03.015
    [15]
    聂娟, 谢丽华, 马港圆, 等. 中药黄芪的化学成分及药理作用研究进展[J]. 湖南中医杂志, 2018, 34(7): 228-231. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZO201807103.htm
    [16]
    ELABD H, WANG H P, SHAHEEN A, et al. Feeding Glycyrrhiza glabra (liquorice) and Astragalus membranaceus (AM) alters innate immune and physiological responses in yellow perch (Perca flavescens)[J]. Fish Shellfish Immunol, 2016, 54: 374-384. doi: 10.1016/j.fsi.2016.04.024
    [17]
    张峰, 高鹏, 彭俊华. 黄芪多糖及黄芪甲苷对巨噬细胞吞噬结核杆菌作用的研究[J]. 西北国防医学杂志, 2005, 26(6): 434-436. doi: 10.3969/j.issn.1007-8622.2005.06.012
    [18]
    马艳春, 胡建辉, 吴文轩, 等. 黄芪化学成分及药理作用研究进展[J]. 中医药学报, 2022, 50(4): 92-95. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXB202204020.htm
    [19]
    赵晓峰, 何海根, 章建萍, 等. 黄芪对免疫功能低下小鼠免疫功能的影响[J]. 浙江中医药大学学报, 2012, 36(6): 749-751. doi: 10.3969/j.issn.1005-5509.2012.06.059
    [20]
    CHO W C, LEUNG K N. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus[J]. J Ethnopharmacol, 2007, 113(1): 132-141. doi: 10.1016/j.jep.2007.05.020
    [21]
    陆鹏, 莫让辉, 梁柱石. 黄芪对免疫无应答艾滋病患者CD4+T淋巴细胞数的影响[J]. 中华实验和临床感染病杂志: 电子版, 2014, 8(2): 108-110. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSGR201402041.htm
    [22]
    QIU H H, CHENG G L, XU J Q, et al. Effects of Astragalus polysaccharides on associated immune cells and cytokines in immunosuppressive dogs[J]. Procedia Vaccinol, 2010, 2(1): 26-33.
    [23]
    唐国廷. 黄芪药理作用与临床应用研究进展[J]. 中医药临床杂志, 2010, 22(9): 844-845. https://www.cnki.com.cn/Article/CJFDTOTAL-AHLC201009040.htm
    [24]
    孙政华, 邵晶, 郭玫. 黄芪化学成分及药理作用研究进展[J]. 中医临床研究, 2015, 7(25): 22-25. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLY201525010.htm
    [25]
    陈文. 托里消毒饮在抗生素骨水泥链珠治疗创伤性骨髓炎中的临床观察[D]. 福州: 福建中医药大学, 2015.
    [26]
    泰阳, 侯建平, 孟建国, 等. 桔梗的药理学研究进展[J]. 现代中医药, 2009, 29(6): 74-75. https://www.cnki.com.cn/Article/CJFDTOTAL-XDZY200906046.htm
    [27]
    邢峰丽, 封若雨, 孙芳, 等. 皂角刺的药理作用研究进展[J]. 环球中医药, 2017, 10(10): 1267-1270. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY201710035.htm
    [28]
    张耀峰. 中药柴胡皂苷药理作用的研究进展[J]. 中医临床研究, 2020, 12(33): 120-121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYLY202033048.htm
    [29]
    吉庆, 马宇衡, 张烨. 白芷的化学成分及药理作用研究进展[J]. 食品与药品, 2020, 22(6): 509-514. https://www.cnki.com.cn/Article/CJFDTOTAL-SDPK202006020.htm
    [30]
    王明华, 赵二劳, 杨洁, 等. 白芷香豆素提取及其药理作用研究进展[J]. 中华中医药学刊, 2023, 41(10): 234-237. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202310048.htm
  • Cited by

    Periodical cited type(1)

    1. 黄艳霞,陈克芳,梁俊雄,曹林辉. 梁俊雄教授运用补托法治疗胸腺瘤经验浅析. 中医临床研究. 2025(01): 51-55 .

    Other cited types(0)

Catalog

    Article views (100) PDF downloads (3) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return